概括
数字工具通过以图形形式呈现患者数据,帮助管理高血压护理. 护士是一个护士.
科学领域:
- 数字健康数字健康
- 护理信息学 护理信息学
- 高血压管理 高血压管理
背景情况:
- 新兴的数字技术为慢性疾病管理中持续监测患者数据提供了新的途径.
- 将患者生成的健康数据整合到临床工作流程中,需要仔细考虑用户参与和数据解释.
- 涉及患者和医疗保健专业人员的共同设计方法可以加强以患者为中心的数字健康工具的开发.
研究的目的:
- 探索护士与新型高血压护理协议的接触,利用患者生成的数据以图形形式呈现.
- 分析血压数据的图形表示如何影响护士与患者的咨询.
- 确定在数字增强的高血压护理中促进有效患者参与的因素.
主要方法:
- 交互分析用于实地检查护士与患者之间的交互.
- 该研究侧重于一项协议,其中连续的患者生成的数据在图表中可视化,用于后续咨询.
- 考虑了护士和患者在共同设计数字卫生基础设施中的角色.
主要成果:
- 图形表示显著结构化的咨询,主要关注血压图.
- 护士表现出三种不同的参与模式:平均数据,调整协议和执行数据分析.
- 有效的患者参与需要护士的叙事诱导与数据分析一起,强调"隐形工作"的重要性.
结论:
- 虽然图形数据构建了咨询,但护士的叙事引发沟通增强了患者的参与度.
- 护士和患者都需要全面的培训,以优化在高血压护理中使用基于图表的协议.
- 进一步开发数字健康工具应将数据可视化与有效的沟通策略相结合,以改善患者的治疗结果.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
375
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375
01:18Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
01:23Antihypertensive Drugs: Vasodilators
463
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
463
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
477
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
477
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
462
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
462